Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in m… Read more
Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) - Total Liabilities
Latest total liabilities as of September 2025: $3.37 Billion USD
Based on the latest financial reports, Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) has total liabilities worth $3.37 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Recordati Industria Chimica e Farmaceutica S.p.A. - Total Liabilities Trend (2019–2024)
This chart illustrates how Recordati Industria Chimica e Farmaceutica S.p.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Recordati Industria Chimica e Farmaceutica S.p.A. Competitors by Total Liabilities
The table below lists competitors of Recordati Industria Chimica e Farmaceutica S.p.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
China | CN¥13.92 Billion |
|
Mitie Group plc
PINK:MITFF
|
USA | $2.05 Billion |
|
Zhefu Holding Group Co Ltd
SHE:002266
|
China | CN¥14.78 Billion |
|
Hella KGaA Hueck & Co
XETRA:HLE
|
Germany | €4.17 Billion |
|
Shaanxi Sirui Advanced Materials Co. Ltd. A
SHG:688102
|
China | CN¥1.23 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Recordati Industria Chimica e Farmaceutica S.p.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Recordati Industria Chimica e Farmaceutica S.p.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Recordati Industria Chimica e Farmaceutica S.p.A. (2019–2024)
The table below shows the annual total liabilities of Recordati Industria Chimica e Farmaceutica S.p.A. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $3.26 Billion | +29.18% |
| 2023-12-31 | $2.52 Billion | +2.82% |
| 2022-12-31 | $2.45 Billion | +70.96% |
| 2021-12-31 | $1.43 Billion | -0.06% |
| 2020-12-31 | $1.44 Billion | -10.85% |
| 2019-12-31 | $1.61 Billion | -- |